Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Equivalents01:26

Pharmaceutical Equivalents

205
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
205
Three-Dimensional Microscopy in Microbiology01:28

Three-Dimensional Microscopy in Microbiology

863
Three-dimensional imaging techniques are essential in cell biology, allowing researchers to visualize intricate cellular structures with high resolution. Two prominent methods, Differential Interference Contrast Microscopy (DIC) and Confocal Scanning Laser Microscopy (CSLM), provide distinct advantages for imaging live and thick specimens, respectively.Differential Interference Contrast MicroscopyDIC microscopy enhances contrast in transparent, unstained samples by converting phase...
863
History of Microbiology01:28

History of Microbiology

10.3K
Microbiology, a scientific field dedicated to the study of microorganisms, has undergone profound development since its inception in the 17th century. Its history is marked by key discoveries and technological advancements that have shaped our understanding of life at the microscopic level and transformed medicine, agriculture, and industry.Early Foundations of MicrobiologyThe early foundations of microbiology were built on groundbreaking observations and the development of pioneering...
10.3K
Two-Dimensional Microscopy in Microbiology01:29

Two-Dimensional Microscopy in Microbiology

1.5K
Two-dimensional (2D) microscopy encompasses a range of optical techniques that capture images within a single focal plane, offering detailed representations of microscopic structures. These techniques are essential in biological and medical research, enabling the visualization of cellular and subcellular structures with different levels of contrast and specificity.There are several major types of 2D microscopy, each with strengths and applications.Bright-Field MicroscopyBright-field microscopy...
1.5K
Key Techniques in Microbiology01:19

Key Techniques in Microbiology

2.4K
Aseptic techniques prevent contamination, ensure experimental accuracy, and protect researchers and microbial cultures. These techniques are essential in clinical, industrial, and research settings where sterility is required.Maintaining Sterility in Laboratory PracticesScientists maintain sterility by sterilizing tools with heat or chemicals, disinfecting work surfaces, and handling cultures in controlled environments. Working near an open flame or within a laminar flow hood reduces the risk...
2.4K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

201
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
201

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From lab to ocean: bridging swimming energetics and wild movements to understand red drum (Sciaenops ocellatus) behavior in a tidal estuary.

The Journal of experimental biology·2026
Same author

<i>When feeling is better than seeing</i> : Adult Zebrafish Ignore Wide-Field Optic-Flow in Laminar, but not Turbulent Hydrodynamic Environments.

bioRxiv : the preprint server for biology·2026
Same author

Active gas camera mass flow quantification (qOGI): Application in a biogas plant and comparison to state-of-the-art gas cams.

The Review of scientific instruments·2024
Same author

Progress toward sustainable influenza vaccination in the Lao Peoples' Democratic Republic, 2012-2018.

Vaccine·2019
Same author

[Effect of non-breathing-related sleep fragmentation on cognitive function in patients with cerebral small vessel disease].

Zhonghua yi xue za zhi·2019
Same author

"I'm obviously not dying so it's not something I need to sort out today": Considering hepatitis C treatment in the era of direct acting antivirals.

Infection, disease & health·2018

Related Experiment Video

Updated: Feb 7, 2026

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
06:29

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Published on: March 3, 2021

6.0K

Rapid Microbiology Screening in Pharmaceutical Workflows.

C Surrette1, B Scherer1, A Corwin1

  • 11 Electronics Organization, GE Global Research Center, Niskayuna, NY, USA.

SLAS Technology
|July 21, 2018
PubMed
Summary

This study presents a rapid microfluidic assay combined with cell filtration for pharmaceutical microbiological screening. This approach significantly reduces testing time for sterility and bioburden, improving drug production workflows.

Keywords:
bacteriabioburdencell processingcell therapymicrofluidicpathogenpharmaceuticalrapid microbiologyscreeningsterility

More Related Videos

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
07:45

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

3.9K
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

909

Related Experiment Videos

Last Updated: Feb 7, 2026

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
06:29

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Published on: March 3, 2021

6.0K
Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
07:45

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

3.9K
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

909

Area of Science:

  • Microbiology
  • Biotechnology
  • Pharmaceutical Science

Background:

  • Conventional microbiology testing methods (e.g., agar plate, microbroth dilution) have long turnaround times.
  • This delay necessitates empirical antibiotic treatment in clinics and causes inefficiencies in pharmaceutical sterility and bioburden testing.
  • Current limitations impact drug production timelines and supply chain logistics.

Purpose of the Study:

  • To develop and demonstrate a proof-of-concept for integrating rapid microbiological tests into pharmaceutical workflows.
  • To address the limitations of conventional methods in pharmaceutical sterility and bioburden testing.
  • To enable in-line sampling and process monitoring in bioreactors.

Main Methods:

  • A combination of a rapid microfluidic assay and an efficient cell filtration process was developed.
  • Demonstrated separation and detection of Escherichia coli from mammalian (CHO) cell culture.
  • Utilized a membrane filtration module compatible with bioreactor sampling.

Main Results:

  • Achieved detection of Escherichia coli with a 3.0-hour incubation time.
  • Successfully separated and analyzed bacteria directly from a mammalian cell culture.
  • The developed system allows for in-line sampling and process monitoring.

Conclusions:

  • The integrated microfluidic assay and filtration system offers a rapid alternative for pharmaceutical microbiological screening.
  • This approach can significantly reduce time-to-result, improving workflow efficiencies in drug manufacturing.
  • The technology enables real-time process monitoring and faster decision-making in pharmaceutical quality control.